Results per Page:
Reading between the cells: How MRD details predict AML relapse
From the Walter Lab, Translational Science and Therapeutics Division
Detecting earliest signs of cancer relapse: Study finds high-throughput sequencing outpaces flow cytometry
Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method